Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib
Condition: Inflammatory Bowel Diseases Intervention: Biological: SHINGRIX Sponsor: Boston Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials